ARCHIVES

EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.

This article is from The Cancer Letter archive.

Vol. 26 No. 46 | December 15, 2000

Download PDF Visit The Full Archive

Related Articles

Komen, Baylr, UT Southwestern Form Alliance

November 13, 1987

Biopsies Could Be Reduced By Computer-Aided-Detection

December 26, 2003

Tumors Harder To Detect In Women In Their Forties

August 27, 2010

Organ Systems Program Progress, Momentum Threatened During transition, Karr Contends

December 9, 1988

In Brief: ACA Executive Committee Votes to Move HQ Out Of New York; Davis Establishes Office In D.C.

April 17, 1987

Northwestern, Rochester, Howard First In Line For Limited Construction Funds

August 20, 1976